about
Glucopyranosyl lipid A adjuvant significantly enhances HIV specific T and B cell responses elicited by a DNA-MVA-protein vaccine regimenTLR4 and TLR7/8 Adjuvant Combinations Generate Different Vaccine Antigen-Specific Immune Outcomes in Minipigs when Administered via the ID or IN RoutesIdentification of the 2B4 molecule as a counter-receptor for CD48Transferrin conjugation confers mucosal molecular targeting to a model HIV-1 trimeric gp140 vaccine antigen.A Phase 1 Human Immunodeficiency Virus Vaccine Trial for Cross-Profiling the Kinetics of Serum and Mucosal Antibody Responses to CN54gp140 Modulated by Two Homologous Prime-Boost Vaccine RegimensEnhanced immunogenicity of an HIV-1 DNA vaccine delivered with electroporation via combined intramuscular and intradermal routesAntibody responses after intravaginal immunisation with trimeric HIV-1 CN54 clade C gp140 in Carbopol gel are augmented by systemic priming or boosting with an adjuvanted formulationMucosal application of gp140 encoding DNA polyplexes to different tissues results in altered immunological outcomes in mice.Global dysfunction of CD4 T-lymphocyte cytokine expression in simian-human immunodeficiency virus/SIV-infected monkeys is prevented by vaccinationIntravaginal immunization using the recombinant HIV-1 clade-C trimeric envelope glycoprotein CN54gp140 formulated within lyophilized solid dosage formsIntramuscular Immunisation with Chlamydial Proteins Induces Chlamydia trachomatis Specific Ocular Antibodies.Discrete partitioning of HIV-1 Env forms revealed by viral capture.Plasmid DNA Vaccine Co-Immunisation Modulates Cellular and Humoral Immune Responses Induced by Intranasal Inoculation in Mice.Mucosal tissue tropism and dissemination of HIV-1 subtype B acute envelope-expressing chimeric virusA Multi-Component Prime-Boost Vaccination Regimen with a Consensus MOMP Antigen Enhances Chlamydia trachomatis Clearance.Pulmonary delivery of DNA vaccine constructs using deacylated PEI elicits immune responses and protects against viral challenge infection.Microneedle mediated intradermal delivery of adjuvanted recombinant HIV-1 CN54gp140 effectively primes mucosal boost inoculations.A Comparative Phase I Study of Combination, Homologous Subtype-C DNA, MVA, and Env gp140 Protein/Adjuvant HIV Vaccines in Two Immunization Regimes.Intravaginal immunisation using a novel antigen-releasing ring device elicits robust vaccine antigen-specific systemic and mucosal humoral immune responses.Expressing anti-HIV VRC01 antibody using the murine IgG1 secretion signal in Pichia pastoris.Molecular investigations into vaginal immunization with HIV gp41 antigenic construct H4A in a quick release solid dosage form.Recruitment and expansion of dendritic cells in vivo potentiate the immunogenicity of plasmid DNA vaccines.CD71 targeting boosts immunogenicity of sublingually delivered influenza haemagglutinin antigen and protects against viral challenge in mice.Vaccine protection against functional CTL abnormalities in simian human immunodeficiency virus-infected rhesus monkeys.Intravaginal immunization using a novel antigen delivery device elicits robust vaccine antigen-specific systemic and mucosal humoral immune responses.Antigen-specific T lymphocyte responses elicited by a DNA – MVA HIV CN54gp140 immunization regime are significantly altered by the TLR4 adjuvant GLA.Immunoglobulin G1 Allotype Influences Antibody Subclass Distribution in Response to HIV gp140 Vaccination.Isolation and Characterization of Antigen-Specific Plasmablasts Using a Novel Flow Cytometry-Based Ig Capture Assay.A heterogeneous human immunodeficiency virus-like particle (VLP) formulation produced by a novel vector system.Advances in HIV-1 Vaccine Development.A systematic analysis of the expression of the anti-HIV VRC01 antibody in Pichia pastoris through signal peptide optimization.Optimisation of ex vivo memory B cell expansion/differentiation for interrogation of rare peripheral memory B cell subset responses.Molecular Signatures of a TLR4 Agonist-Adjuvanted HIV-1 Vaccine Candidate in Humans.Evaluation of CD62L expression as a marker for vaccine-elicited memory cytotoxic T lymphocytes.One Size Does Not Fit All: The Effect of Chain Length and Charge Density of Poly(ethylene imine) Based Copolymers on Delivery of pDNA, mRNA, and RepRNA Polyplexes.Corrigendum: Immunoglobulin G1 Allotype Influences Antibody Subclass Distribution in Response to HIV gp140 Vaccination.Evidence of NK cell dysfunction in SIV-infected rhesus monkeys: impairment of cytokine secretion and NKG2C/C2 expression.P11-06. Intravaginal administration of HIV-1ZM96 gp140 augments systemic and mucosal antibody responses following systemic priming with adjuvanted protein.Rational Design of DNA-Expressed Stabilized Native-Like HIV-1 Envelope TrimersP11-09. Mucosal vaccination with a transferrin-gp140 conjugate via the nasal but not vaginal route elicits robust systemic and vaginal IgG and IgA responses
P50
Q21089693-00D46FE4-3844-4C8E-9FB2-CB286B42E52CQ27322386-4C77D437-A03B-464D-A965-473C002C6209Q28290159-EC9B35D9-88E6-45F4-8F6B-23717ABDC59AQ30468622-9EC8219D-0581-480F-8742-99067C119B3DQ33720317-4AA10C54-AE5C-4DE1-A26F-A50B38AA3ABFQ33743758-EF78B6CD-84A2-46FC-B0B4-43B3BD069066Q34694812-2BE1D35F-BB48-4430-ACFA-3550A82AA80BQ34797176-D8078332-916B-49F7-9858-AE41DFABFFD4Q34858697-337228EB-A126-488F-BA8D-159AB8A09424Q35061979-2CDD69F0-5D4E-4CBC-B34B-94D2DC0B0C90Q35821088-C8BD3F75-2039-4C2E-8C35-53BAE4FF53D9Q36088254-C3E70273-A41D-43E2-AB60-89777FAD118EQ36257975-F3D4FF34-94CF-4CDF-BD30-328DAE2E4A4EQ36559660-BA26AD33-B3AC-4BAD-80F3-184601B4B617Q36845154-B61D0C5F-45E1-462D-A2F8-139DEF9EA250Q37156309-8E4A2610-3E73-472C-8FD1-F4D27E90E929Q37187433-6590B4D5-8F3B-4071-B8F5-C55D0F421500Q37656908-888928A2-AE2B-48EE-B6D0-479D05380E0EQ37677269-288C0EB1-63E5-4A9E-9AC0-0D802FC72608Q37721762-92CC198E-A909-4DC7-BE90-FE4F40F26CB8Q39648706-C2779A15-7614-4AC2-BC98-7D38771FA588Q40247465-8859BB1D-308F-4DDD-9A8D-FCBC439E0AFBQ40707736-FCF29D56-D41F-46FE-A6A6-A86267B5FA4EQ45734422-59B5CEDD-EDC0-47FC-BE42-02FEC4043426Q46338490-5AC1BD78-FFE8-444E-931E-449E7DBDCBC0Q47103409-B91E18A4-F110-4ADE-B15A-C0649D04A068Q47384731-2F0563EC-800B-4980-876C-5326B98D3626Q47423643-1D6D8C9C-7E1B-4FAA-A1D3-10BA7EDD2626Q47549087-209B15B5-1F41-4C2D-9644-D8162B6A014FQ52609661-FEC9FC17-53F9-4D63-AF4C-D7F2F252BD72Q52618739-364B9408-1CBF-4781-AAC4-8E05FE5F3EE0Q52626499-816D1630-AADD-4163-B975-DFB25A1873E7Q52657155-25E667D2-24D4-4E9A-980B-48BE7CBE14E2Q53647091-4708BF3E-1F8D-4147-8E18-83C3B84CE43EQ54227495-161763B0-36DA-4DE2-9A20-8D749517BE9CQ54261564-8BBE8884-AD89-40ED-A0B0-3A2EFC3EB7A6Q54587667-83543A16-86C4-4E32-968D-2760D17A9EECQ55644692-D2BA80BB-75AD-416D-8530-F7D67A511F4EQ58721980-1C2811C2-E11D-490B-8064-41233D1BCA69Q59219873-5A689E5B-3544-48D8-AE75-6A362779A969
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Paul F McKay
@ast
Paul F McKay
@en
Paul F McKay
@es
Paul F McKay
@nl
Paul F McKay
@sl
type
label
Paul F McKay
@ast
Paul F McKay
@en
Paul F McKay
@es
Paul F McKay
@nl
Paul F McKay
@sl
prefLabel
Paul F McKay
@ast
Paul F McKay
@en
Paul F McKay
@es
Paul F McKay
@nl
Paul F McKay
@sl
P106
P21
P2798
P31
P496
0000-0001-5195-6254